Remibrutinib versus teriflunomide in relapsing multiple sclerosis (REMODEL-1 and REMODEL-2): two randomised, phase 3 trials. (linkinghub.elsevier.com)

Authors: Wiendl H … Montalban X Journal: The Lancet Published: 2026-10-23 DOI: https://doi.org/10.1016/S0140-6736(26)02058-1